‘I’m still alive’: Elon Musk reveals his unusual breakfast choice, joining other...
source link: https://finance.yahoo.com/news/m-still-alive-elon-musk-152529875.html
Go to the source link to view the article. You can view the picture content, updated content and better typesetting reading experience. If the link is broken, please click the button below to view the snapshot at that time.
‘I’m still alive’: Elon Musk reveals his unusual breakfast choice, joining other big-name CEOs with strange eating habits
Octopus, a bowl of ice cream, eight oatmeal biscuits, and a donut.
It's an unusual order, but one you may hear if you went for breakfast with some of the biggest names in the corporate world.
Elon Musk is not only using Twitter to update users on company news, insult Bill Gates, and reveal Tesla projects, he's also giving an insight into his personal life.
More specifically, his breakfast.
Peter Diamandis, one of the founding partners of health care business Fountain Life, tweeted earlier this week that "sugar is poison."
Musk responded: "I eat a donut every morning. Still alive" to which Diamandis responded: "Okay Elon, allow me to be more specific. Sugar is a slooow poison."
The exchange gave an insight into the lifestyle of the SpaceX founder, who was the victim of internet body-shaming when a shirtless image of him on a yacht with talent agency boss Ari Emmanuel went viral.
Musk’s daily doughnut ritual runs parallel to his previous statement on health and nutrition.
In 2020, he told Joe Rogan in a podcast interview, “I’d rather eat tasty food and live a shorter life.”
But Musk is in good company when it comes to big-name CEOs giving in to their sugar cravings.
Warren Buffett
Now into his nineties, Buffett has always had a weakness for sweet foods. In 2015 he told Fortune he was "one-quarter Coca-Cola," saying he drinks at least five 12-ounce servings every day. Buffett has 400 million shares in the fizzy drink brand through his company, Berkshire Hathaway, and even lent his likeness to the cans on sale in China in a bid to boost sales.
His first Coke of the five cans he drinks a day is consumed with a tub of "potato stix" shoestring snacks, though the man worth $106 billion sometimes likes to switch up his routine by substituting a bowl of ice cream for the crisps.
Microsoft cofounder Bill Gates, Buffett's friend and fellow billionaire, revealed that the rest of the veteran investor's diet largely comprises McDonald's hamburgers—a brand Buffett also has a stake in—and snacks like Oreos.
- Fortune
One of the world’s richest men knows why Silicon Valley Bank really failed: ‘People on iPhones’
Stephen Schwartzman, worth $42 billion and at the head of a firm managing almost $1 trillion, says social media is what doomed the bank.
4h ago - Fortune
‘All layoffs are bad:’ Recent Salesforce and Meta job cuts show even good severance packages won’t soften the blow for workers
“Just be honest with us.” Layoffs are sometimes inevitable, but workers say transparency and compassion go a long way to softening the blow.
5h ago - Benzinga
Is ChatGPT-4 The Ultimate Side Hustle? Writer Using It To Turn $100 Into A $100,000 Viral Business
Writer and brand designer Jackson Greathouse Fall tweeted on March 15, 2023 about his experiment with ChatGPT-4 and his new venture called “HustleGPT.” ChatGPT-4 is the latest tool from OpenAI, a pioneer in an intelligent chatbot with the potential to transform daily life and multiple industries. His initial query to ChatGPT-4 read "You are HustleGPT, an entrepreneurial AI. I am your human counterpart. I can act as a liaison between you and the physical world. You have $100, and your only goal i
6h ago - Fortune
Elon Musk and Apple cofounder Steve Wozniak among over 1,100 who sign open letter calling for 6-month ban on creating powerful A.I.
The letter calls on technology companies and governments to create safety standards and control mechanisms for powerful A.I. before resuming work on developing such systems.
1d ago - Benzinga
GSK Bets On Scynexis' FDA-Approved Antifungal Drug For Over $500M In Bio Bucks
GSK plc (NYSE: GSK) and Scynexis Inc (NASDAQ: SCYX) have entered into an exclusive license agreement for Brexafemme (ibrexafungerp tablets). The FDA approved the antifungal for vulvovaginal candidiasis (VVC) and reduced the incidence of recurrent VVC (RVVC). This exclusive agreement gives GSK rights to commercialize Brexafemme for VVC and RVVC while continuing to develop ibrexafungerp, which is in phase 3 trials for potentially treating invasive candidiasis (IC), which affects the blood or inter
3h ago - Investor's Business Daily
Avidity Bio Crashes 17% After 'Rarer Than Rare' Event Sidelines Key Study
A key study from Avidity Biosciences remains on hold after a patient experienced a rare side effect, leading RNA stock to plummet Thursday.
18m ago - Investor's Business Daily
Is Pfizer Stock A Buy Or A Sell On Its Looming $43 Billion Seagen Takeover?
Is Pfizer stock a buy or a sell after the company announced its $43 billion plan to buy Seagen? Is PFE stock a buy or a sell?
1d ago - Zacks
Biotech Stock Roundup: VKTX, BMEA, ITCI Soar on Study Data, INCY Faces Setback
Pipelines updates from Viking Therapeutics (VKTX) and Intra-Cellular (ITCI) are the key highlights for the biotech sector.
1d ago - Investopedia
Top 3 Telemedicine Companies for 2022
Telemedicine companies that represent a growing segment of the health care sector are seeing a surge in popularity both from investors and consumers.
23h ago - Investor's Business Daily
Novo Hits Another Record High As WHO Considers A Key Move In Obesity
The World Health Organization will consider adding obesity treatments to its "essential medicines list." The move could help some drug stocks.
1d ago - Reuters
India exempts import tax on pricey rare disease medicines
The Indian government said on Thursday it was providing a full exemption from basic customs duty for rare disease therapies and Merck & Co Inc's cancer therapy Keytruda when such medicines were imported for personal use. The government said in a statement that while some drugs such as treatments for spinal muscular atrophy or Duchenne muscular dystrophy are already exempted from customs duty, it had received many requests for relief from import tax for other rare disease drugs.
11h ago - Fortune
4 signs you’re working with a toxic person—and what to do about it
It’s not always as clear-cut as Trump’s behavior when you’re dealing with a toxic person in the office.
1d ago - Zacks
Intra-Cellular (ITCI) Depression Drug Meets Study Goal, Stock Up
Intra-Cellular Therapeutics (ITCI) announces positive top-line data from its phase III study evaluating lumateperone for the treatment of depression. Stock surges 16% following the news.
1d ago - The Wall Street Journal
Dreaded Medical Paperwork Required by Health Insurers to Be Trimmed
Prior authorization has generated so much resentment in recent years that some health insurers have been making tweaks.
1d ago - AP Finance
FDA approves over-the-counter Narcan. Here's what it means
The U.S. Food and Drug Administration on Wednesday approved selling the leading version of naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid treatment drug to be sold over the counter. WHAT IS NARCAN? The approved nasal spray from Gaithersburg, Maryland-based Emergent BioSolutions is the best-known form of naloxone.
1d ago - Investor's Business Daily
Is Moderna Stock A Sell As Senators Eye 400% Price Hike For Covid Shots?
Moderna stock is under pressure as the company contends with a pitfall in Covid shots and plans for a 400% price hike. Is MRNA stock a sell?
1d ago - Barrons.com
What WHO’s New Covid-19 Vaccine Guidance Means for Pfizer and Moderna Stock
The two companies have said they expect roughly 100 million Covid-19 vaccines doses to be administered in the U.S. this year.
1d ago - News Direct
Poolbeg Pharma "in a very healthy cash position" after first full year of operations
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive after publishing final results for 2022 that show that the clinical-stage biotech company finished its first fu...
12h ago - Benzinga
FDA Approves First OTC Naloxone Nasal Spray For Opioid Overdose
The FDA has approved Emergent BioSolutions Inc's (NYSE: EBS) Narcan, 4 milligrams (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription use – the first naloxone product approved for use without a prescription. Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard treatment for opioid overdose. The move paves the way for the medication to reverse an opioid overdose to be sold directly to consumers in drug stores, convenienc
1d ago - Quartz
American women could be one Texas ruling away from losing access to mifepristone
American women looking to end a pregnancy might soon be unable to take mifepristone, a drug used for medication abortion through the 10th week of pregnancy. A federal court in Texas is expected to rule on a lawsuit it heard earlier this month seeking to revoke the FDA’s authorization of the medication, which was issued in 2000.
22h ago
Recommend
About Joyk
Aggregate valuable and interesting links.
Joyk means Joy of geeK